Nextleaf Solutions Ltd. (“Nextleaf”, “OILS”, or the “Company”) (CSE:OILS, OTCQB:OILFF, FSE:L0MA) announced today it has been granted a U.S. patent pertaining to the Company’s proprietary technology for post-extraction processing of THC and CBD.

The patent extends the Company’s existing patent portfolio, to include methodology relating to the removal of fats and waxes from crude cannabis oil extracts in far less time, achieving more efficient throughput rates, and a highly desirable, impurity-free, refined distillate. Nextleaf can apply this advantage to a variety of primary extraction methods, such as CO2 or ethanol.


“Since 2017, we’ve been hyper-focused on acquiring, developing, and protecting IP around the underlying technology that goes into transforming plant into product,” stated Paul Pedersen, CEO of Nextleaf. “Our technology is based around what we believe to be the most efficient method to go from dried cannabis biomass into a high-purity THC or CBD rich distillate, in an efficient and truly scalable way. This being our fourth issued patent, further strengthens Nextleaf’s intellectual property portfolio pertaining to industrial-scale cannabis extraction and purification.”

The infused-product industry is projected to be $2.7 billion per year in Canada alone, driven largely by shifting consumer preferences from dried flower to edibles, vapes and concentrates. The Company believes IP around methodology and formulation of how those products are manufactured efficiently at scale will be one of the key differentiators in the industry.

“One of the biggest issues with infused products relates to taste. With crude extracts and less refined oils, the consumer experience is affected by inferior taste and smell because of the chlorophyll, fats, and waxes,” said Pedersen. “Nextleaf is able to fix those issues through its proprietary processing methodologies and equipment, which we’ve protected through a portfolio of four issued and 25 pending patents.”

“We believe the success of every producer in the cannabis industry will ultimately come down to the quality of their product, and the cost per milligram to create that product,” said Pedersen. “By having a technology advantage protected by defendable intellectual property, OILS will be able to drive low-cost production and maintain a competitive advantage and leadership position.”

Nextleaf’s IP department is focused on obtaining broad, worldwide patent coverage for the Company’s innovative methodologies and equipment, with an emphasis on the United States and Canada. Once cannabis oils, edibles and concentrates become legal, the Company plans to begin commercializing its intellectual property in jurisdictions where cannabis is federally legal.

About Nextleaf Solutions

Nextleaf Solutions Ltd. (“OILS”) is the first publicly traded company to be issued a U.S. patent for the industrial-scale extraction and purification of cannabinoids. OILS owns a portfolio of four (4) issued and 25 pending patents pertaining to the production of high-purity cannabinoid distillate, the precursor used in the manufacturing of standardized THC and CBD based products. Once cannabis concentrates become legal across Canada on October 17, 2019, the company plans to commercialize its intellectual property portfolio through IP licensing, and B2B processing services.

Nextleaf Solutions trades as OILS on the Canadian Securities Exchange (CSE: OILS), OILFF on the OTCQB Market in the United States (OTCQB: OILFF) and L0MA on the Frankfurt Stock Exchange (FSE: L0MA).

Contact:

Adel Fares, Investor Relations
604-283-2301 (ext. 201)
investors@nextleafsolutions.com

For more information about Nextleaf visit www.nextleafsolutions.com or follow OILS across social media platforms: Twitter, LinkedIn, Facebook, Instagram and YouTube.

CAUTIONARY STATEMENT:
The securities described herein, if any, have not been, and will not be, registered under the United States Securities Act of 1933, as amended (the “U.S. Securities Act”), or any state securities laws, and may not be offered or sold within the United States or to, or for the benefit of, U.S. persons (as defined in Regulation S under the U.S. Securities Act) except in compliance with the registration requirements of the U.S. Securities Act and applicable state securities laws or pursuant to exemptions therefrom. This release does not constitute an offer to sell or a solicitation of an offer to buy of any of Nextleaf Solutions securities in the United States. This news release may contain “forward-looking information” as defined in applicable Canadian securities legislation. All statements other than statements of historical fact included in this release, including, without limitation, future operating margins, future production and processing, processing results, and future plans and objectives of Nextleaf Solutions, constitute forward looking information that involve various risks and uncertainties. Forward-looking information is based on a number of factors and assumptions which have been used to develop such information but which may prove to be incorrect, including, but not limited to, assumptions in connection with the continuance of Nextleaf Solutions and its subsidiaries as a going concern, general economic and market conditions, price of biomass, the accuracy of production resource estimates, and the performance of Nextleaf Solutions future operations. There can be no assurance that such information will prove to be accurate and actual results and future events could differ materially from those anticipated in such forward-looking information. Important factors that could cause actual results to differ materially from Nextleaf Solutions’ expectations include but are not limited to: changes in economic conditions or financial markets; increases in costs; litigation; legislative, environmental and other judicial, regulatory, political and competitive developments; and technological or operational difficulties. This list is not exhaustive of the factors that may affect our forward-looking information. These and other factors should be considered carefully, and readers should not place undue reliance on such forward-looking information. For additional information with respect to risk factors applicable to Nextleaf Solutions, reference should be made to Nextleaf Solutions continuous disclosure materials filed from time to time with securities regulators, including, but not limited to, Nextleaf Solutions CSE Listing Statement. The forward-looking information contained in this release is made as of the date of this release. Nextleaf Solutions does not intend, and expressly disclaims any intention or obligation to, update or revise any forward-looking information whether as a result of new information, future events or otherwise, except as required by applicable law. The CSE has not reviewed, approved or disapproved the contents of this press release. To contact the Company, email investors@nextleafsolutions.com

Click here to connect with Nextleaf Solutions Ltd. (CSE:OILS, OTCQB:OILFF, Frankfurt:L0MA) for an Investor Presentation.

Source: www.newswire.ca

Online ordering and doorstep delivery have become the new normal as patients and consumers continue to rely on convenient and sustainable delivery services

World-Class Extractions Inc. (CSE:PUMP) (FRA:WCF) (OTCQB:WCEXF) (“Company” or “World-Class”), is pleased to provide an update on Pineapple Express Delivery Inc. (“Pineapple Express Delivery” or “PED”), a company in which World-Class has a controlling interest. PED is a leading logistics technology company offering compliant and secure delivery of controlled substances and regulated products, including medical and recreational cannabis delivery in Ontario, Manitoba and Saskatchewan, and liquor delivery in certain jurisdictions in Saskatchewan

Pineapple Express Delivery – Highlights

The following PED revenues comprise of delivery services of medical and recreational cannabis within Ontario and Manitoba to various Business-to-Consumer and Business-to-Business licensed producer companies and liquor deliveries in Saskatchewan:

  • December 2020 revenues totaled $889,935 (November – $837,875) with gross margin of 34% (November – 30%) (unaudited).
  • November 2020 revenues totaled $837,875 (October – $795,580) with gross margin of 30% (October – 30%) (unaudited).
  • As a result of recent COVID-19 prevention measures, B2C revenue increased approximately 7% in November over October 2020 and an additional 4% in December over November 2020, mainly from an increase in the recreational delivery segment.
  • During 2020:
    • monthly revenue grew from $131,179 in January 2020 to $889,935 in December 2020, representing an increase of 578%; and
    • number of deliveries grew from 11,077 in January 2020 compared to 70,802 in December 2020, representing an increase of 539%.

The Company cautions that figures for revenue, gross profit and net income generated from the services offered by Pineapple Express Delivery have not been audited beyond April 30, 2020 and are based on calculations prepared by the management of Pineapple Express Delivery. Actual results may differ from those reported in this release once figures have been audited.

Pineapple Express Delivery – Operational Achievements

Since the Company’s acquisition of a controlling interest in PED, PED has achieved the following operational milestones:

  • In addition to continuing to offer premium delivery services for recreational and medical cannabis products, PED expanded its delivery services to provide same-day and next-day delivery of wine, spirits and beer products from Saskatoon Co-op’s Wine-Spirits-Beer retail stores in Saskatoon, Warman and Martensville.
  • The number of cannabis and alcohol deliveries continues to increase month over month with 67,279 deliveries rendered in November, and 70,802 in December, compared to 62,327 deliveries in October.
  • The number of drivers increased from 55 at the beginning of 2020, to approximately 200 by December 2020. Efficiencies have also been created by routing deliveries through hub expansions and concentrating drivers to tighter geographical areas, leading to less hours used by drivers for the timely delivery of packages.
  • Within the province of Ontario, PED offers same day cannabis delivery service in 37 cities (183 postal code regions) and 3-day service in 65 cities (288 postal code regions).
  • Expanded its services into the Ontario cities of Ottawa, Barrie, London and also into the Windsor/Chatham region.
  • Launched and commenced operations of PED cannabis depots (hubs) in Ottawa, Kingston, London and in the Windsor/Chatham region.
  • Partnered with Medical Cannabis by Shoppers™ to offer same-day delivery to their medical cannabis patients in cities in and around the Greater Toronto Area (GTA). Medical Cannabis by Shoppers™ is Shoppers Drug Mart’s online platform for the sale of medical cannabis.
  • Partnered with Spectrum Therapeutics, the medical division of Canopy Growth Corporation to bring same-day delivery to medical cannabis patients in the GTA, from Hamilton to Scarborough. This builds on PED’s existing services contract with Canopy Growth which offers same-day delivery services for Tweed and Tokyo Smoke retail stores in Manitoba and Saskatchewan.
  • Subsequent to the period ending October, 31, 2020, PED entered into a licensing agreement to provide software and support services to an arm length party. PED shall provide set-up, implementation and development of the software and shall provide support to all locations catered to by the other party.
  • Several contracts in place with Health Canada License Holders for delivery within select provinces in Canada.
  • Late-stage applicant to Health Canada to obtain a ‘Sale for Medical Purposes’ license for its facility located in the GTA. With a population of 6-million people, this sales license gives PED the ability to store inventory for other license holders, allowing PED to leverage its facility in the GTA and offer same day delivery services to the patients of those LPs.

Pineapple Express Delivery – Expansion Strategies

Pineapple Express Delivery continues to advance into new territories, offering safe and secure delivery opportunities to better serve the public. PED anticipates its revenues will increase over the coming months resulting from jurisdictional expansion and continuously improving and expanding its delivery services offerings:

  • Working to launch in three (3) new jurisdictions in Ontario.
  • Working to launch alcohol delivery to service the GTA.
  • Continuing growth of deliveries for the B2B sector which has seen month-over-month increases in revenue since May 2020.
  • Expects to launch prescription medication delivery in British Columbia and the GTA in the near term.

Pineapple Express Delivery – Growth in Delivery Services: COVID-19 and Beyond

Aspiring to be the ‘Amazon’ of regulated product deliveries, Pineapple Express Delivery is based in Burlington, Ontario, providing B2C and B2B delivery options for controlled substances and regulated products deliveries (cannabis, alcohol and prescription products). PED is currently one of the premiere, most utilized delivery services in Ontario, and will continue to maintain its high standards of security and compliance for same day and next day parcels, even as it grows to meet provincial need.

PED benefits from a management team with over 10 years of experience offering same-day delivery services in multiple industries across Canada. Its founder, Randy Rolph, founded Menu Express delivery in Quebec in 2010, which was subsequently purchased by Just Eat in 2014. Mr. Rolph then founded Delivery Direct in 2015, becoming the national leader in 60 min delivery. The proprietary logistics software behind Just Eat and Delivery Direct brings the most reliable same-day, last mile delivery services for the controlled substances and regulated market across Canada.

The COVID-19 pandemic has forever changed shopping behaviours. With the unfortunate outbreak of COVID-19 and the cannabis sector deemed an ‘essential’ service, there has been a surge in demand for delivery with more and more people staying indoors and practicing social distancing. Cannabis patients and consumers have embraced delivery to safely access regulated products, and PED is experiencing increased demand for its services. In response to this surge in volume, PED has increased the number of delivery drivers to over 200 in 2020.

An increase in deliveries during a health crisis also equates to an increase in routine and preventative measures. As such, PED has implemented strict COVID-19 practices and procedures in its offices, warehouses, and in delivery driver procedures, including equipping all driver vehicles with a 360º security camera. PED ensures that its staff has the necessary tools to abide by Health Canada and provincial health guidelines, including face coverings, gloves, hand sanitizer, and disinfectants.

Rosy Mondin, CEO of World Class Extractions stated, “The COVID-19 pandemic has created an urgent demand for home delivery like we’ve never seen before and it’s unlikely that Canadians will ever return to their old shopping habits. People shop online because of convenience – and online shopping and delivery of legal cannabis is no different. E-commerce is thriving, and according to a recent Paypal study, online shopping increased by 53% as more people self-isolated and worked from home, and over 45% of consumers also used home delivery[1]”. Ms. Mondin continued, “Given the history of cannabis legalization, there still exists a lingering stigma of physically visiting retail cannabis stores for many new consumers. After months of lockdown and social distancing pushing more patients and consumers online, Canadians have come to value the convenience of a legal, proven and reliable delivery solution for cannabis and other regulated products, a trend that is likely to stay.”

Randy Rolph, Founder & CEO of Pineapple Express Delivery stated, “In 2020, we have seen the public health and economic crises of the COVID-19 pandemic take a terrible toll on many Canadians and Canadian businesses and we are proud to be a platform that so many Canadians have been able to use to during these difficult times. The guiding principles of PED is that patients and consumers should be able to receive their regulated product orders (alcohol, prescription medications and cannabis) as quickly, safely and as easily as they can obtain any other product in Canada. The pandemic is far from over and many of the habits formed during this pandemic will likely stick post-pandemic. PED’s widespread network and large delivery fleet provides important, much-needed access to thousands of patients and consumers every day.”

About World-Class

World-Class is an innovation-driven company with a principle focus on the rapidly evolving cannabis and hemp industries. World-Class offers compliant and secure delivery of government regulated products through its subsidiary Pineapple Express Delivery Inc., including medical and recreational cannabis in Ontario, Manitoba and Saskatchewan, and liquor delivery in certain jurisdictions in Saskatchewan. World-Class continues to investigate opportunities to deploy and manage custom-built extraction centres utilizing its custom systems, technology, and processes to efficiently produce high-quality cannabis and hemp concentrates and end-products.

Investor Contact
World-Class Investor Relations
1-437-266-1968
ir@worldclassextractions.com
https://worldclassextractions.com

Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this press release, which has been prepared by management.

Cautionary Note Regarding Forward-Looking Statements

All statements in this press release, other than statements of historical fact, are “forward-looking information” with respect to the Company within the meaning of applicable securities laws, and the ability of Pineapple Express Delivery to expand its delivery services and to provide discrete shipment of products. The Company provides forward-looking statements for the purpose of conveying information about current expectations and plans relating to the future and readers are cautioned that such statements may not be appropriate for other purposes. By its nature, this information is subject to inherent risks and uncertainties that may be general or specific and which give rise to the possibility that expectations, forecasts, predictions, projections or conclusions will not prove to be accurate, that assumptions may not be correct and that objectives, strategic goals and priorities will not be achieved. These risks and uncertainties include but are not limited those identified and reported in the Company’s public filings under the Company’s SEDAR profile at www.sedar.com. Although the Company has attempted to identify important factors that could cause actual actions, events or results to differ materially from those described in forward-looking information, there may be other factors that cause actions, events or results not to be as anticipated, estimated or intended. There can be no assurance that such information will prove to be accurate as actual results and future events could differ materially from those anticipated in such statements. The Company disclaims any intention or obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise unless required by law.

Keep reading... Show less

AMP German Cannabis Group Inc. (” AMP “) (CSE: XCX ), ( Frankfurt : C4T ) (ISIN: CA00176G1028) and Aphria Inc.’s (” Aphria “) (TSX: APHA ) (NASDAQ: APHA) wholly-owned German subsidiary, CC Pharma GmbH (” CC Pharma “), have entered into a strategic agreement (the ” Co-Promotion Agreement “) covering joint marketing of sales for Aphria brand medical cannabis products for the German market.

The Co-Promotion Agreement is a collaboration contract between AMP and CC Pharma to sell the Aphria medical cannabis brand in Germany . In addition, AMP will organize with the support of CC Pharma, “information events” in Germany to market Aphria branded products to doctors and pharmacists.

Keep reading... Show less

Progressive Planet Solutions Inc. (TSXV: PLAN) (“PLAN” or the “Company”), is pleased to announce a non-brokered private placement offering of up to 7,000,000 units (” Units “), at $0.20 per unit, for total gross proceeds of up to $1,400,000 .

Keep reading... Show less

 Progressive Planet Solutions Inc. (TSXV: PLAN) (“PLAN” or “Progressive Planet”), announces that it has engaged C&CS Atlantic Inc. to complete  testing required to commercially launch PozGlass SCM. The principal of C&CS Atlantic is Dr. Michael Thomas .

Keep reading... Show less